Follicular lymphoma trials in United States

In United States 103 Also abroad 188

103 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy
Where
Albert Lea, Eau Claire, Jacksonville, La Crosse, Mankato, Rochester, Scottsdale
Age
18 years and over
People
41
Run by
Mayo Clinic
See details and how to joinNCT06834373
Phase 1Not yet taking people in United States
Axatilimab + CAR-T for High-Risk Lymphoma
Where
Atlanta
Age
8 years and over
People
29
Run by
Northside Hospital, Inc.
See details and how to joinNCT07638982
Phase 1Taking people
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Where
Anaheim, Austin, Boston, Dallas, Duarte, Fairfax, Fairway, Hackensack, Irving, Kansas City, Louisville, Myrtle Beach, Nashville, Newton, Norwalk, Oklahoma City, Omaha, Overland Park, Port Angeles, Poulsbo, Rockville, San Antonio, Seattle, Tucson, Westwood
Age
18 years and over
People
453 worldwide
Run by
Pfizer
See details and how to joinNCT03460977 · EU 2023-509179-18-00
Phase 2Taking people
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Where
Albuquerque, Atlanta, Baltimore, Baton Rouge, Battle Creek, Boiling Springs, Boise, Burlington, Charleston, Charlotte, Chicago, Cleveland, Clinton Township, Concord, Costa Mesa, Danville, Dearborn, Detroit, Durham, Easley, Fargo, Farmington Hills, Fayetteville, Fruitland, Gainesville, Grand Rapids, Greenville, Greer, Iowa City, Irvine, Jackson, Kalamazoo, Kansas City, Laguna Hills, Lebanon, Little Rock, Louisville, Madison, Maywood, Memphis, Meridian, Milwaukee, Muskegon, Nampa, Newberg, New Berlin, New York, Niles, Norton Shores, Novi, Oklahoma City, Orange, Oregon City, Overland Park, Philadelphia, Portland, Reed City, Richmond, Rochester, Rogers, Saint Johnsbury, Saint Joseph, San Francisco, Seattle, Seneca, Southfield, Springdale, Traverse City, Tucson, Twin Falls, Webster, West Bloomfield, Westwood, Wilkes-Barre, Winston-Salem, Wyandotte, Wyoming
Age
18 years and over
People
396
Run by
SWOG Cancer Research Network
See details and how to joinNCT05633615
Phase 1Taking people
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
Where
East Brunswick, Grand Rapids, Houston, Jacksonville, Los Angeles
Age
18 years and over
People
180 worldwide
Run by
Ascentage Pharma Group Inc.
See details and how to joinNCT07424833
Phase 2Taking people
Tafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicular Lymphoma
Where
Seattle
Age
18 years and over
People
30
Run by
University of Washington
See details and how to joinNCT07731789
Phase 2Not yet taking people in United States
Prizloncabtagene Autoleucel (Prizlon-cel) for the Treatment of Relapsed or Refractory Large B-cell Lymphoma Post FDA Approved CAR T-cell Therapy
Where
Gilbert, La Jolla
Age
18 years and over
People
55
Run by
AbelZeta Inc.
See details and how to joinNCT07875413
Phase 2Taking people
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Where
Austin, Charlotte, Chicago, Columbus, Duarte, Houston, Iowa City, Jacksonville, Milwaukee, Nashville, New Brunswick, New York, Overland Park, Philadelphia, Phoenix, Pittsburgh, Portland, Rochester, San Antonio, St Louis, Tampa, Waukee
Age
18 years and over
People
270 worldwide
Run by
AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00
Phase 1Taking people
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
Where
Boston
Age
18 years and over
People
24
Run by
Marcela V. Maus, M.D.,Ph.D.
See details and how to joinNCT06026319
No phaseTaking people
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Where
Bethesda, Charlotte, Cincinnati, Columbus, Fargo, Iowa City, Maumee, Reno, Rochester, Sioux Falls, St Louis, York
Age
0 years and over
People
550
Run by
Tempus AI
See details and how to joinNCT07154823
Phase 2Taking people
Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Where
Duarte
Age
18 years and over
People
36
Run by
City of Hope Medical Center
See details and how to joinNCT05672251
Phase 3Taking people
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
Where
Hattiesburg, Indianapolis, Lebanon, Los Angeles, Plantation, Stony Brook, Waukesha, Westbury
Age
18 years and over
People
580 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06149286 · EU 2022-503092-28-00
Phase 3Taking people
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Where
Boston, Chapel Hill, Charlotte, Charlottesville, Cleveland, Detroit, Hattiesburg, Houston, Los Angeles, Nashville, New York, Noblesville, Orange, Richmond, Salt Lake City, Stony Brook, Tucson, Tyler, Waukesha, Westbury
Age
18 years and over
People
822 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06091254 · EU 2022-502660-20-00
Phase 2Taking people
Emapalumab Prevention of CAR-T Cell Associated Toxicities
Where
Boston
Age
18 years and over
People
28
Run by
Marcela V. Maus, M.D.,Ph.D.
See details and how to joinNCT06550141
Phase 1Taking people
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Where
Ann Arbor, Aurora, Chicago, Detroit, Duarte, Houston, Los Angeles, New York, Pittsburgh, Scottsdale
Age
18 years and over
People
46
Run by
SciTech Development, Inc.
See details and how to joinNCT04234048
Phase 1/2Taking people
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Where
Augusta, Baton Rouge, Bethesda, Birmingham, Boston, Buffalo, Chattanooga, Detroit, Fort Collins, Houston, Iowa City, Jacksonville, La Jolla, Las Vegas, Louisville, Miami, Nashville, Newnan, New York, Palo Alto, Phoenix, Richmond, Rochester, Santa Monica, Scottsdale, Seattle, Tampa, Tucson, Zion
Age
18 years and over
People
689 worldwide
Run by
BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00
Phase 1/2Taking people
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Where
Boston, Charlotte, Hackensack, Houston, La Jolla, New York, Rochester, Seattle, Winston-Salem
Age
18 years and over
People
174 worldwide
Run by
AstraZeneca
See details and how to joinNCT06542250
Phase 2Taking people
Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
Where
Tampa
Age
18 years and over
People
43
Run by
H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06350318
Phase 2Taking people
Epco, Zanu, Ritux for R/R FL or MZL
Where
Boston, Columbus, New York
Age
18 years and over
People
71
Run by
Reid Merryman, MD
See details and how to joinNCT06563596
No phaseTaking people
Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
Where
Portland
Age
18 years and over
People
45
Run by
OHSU Knight Cancer Institute
See details and how to joinNCT06784167
Phase 2Taking people
Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma
Where
Duarte, Irvine
Age
18 years and over
People
41
Run by
City of Hope Medical Center
See details and how to joinNCT06453044
Phase 1Taking people
huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma
Where
Philadelphia
Age
18 years and over
People
6
Run by
University of Pennsylvania
See details and how to joinNCT07343934
Phase 1Enrolling by invitation
CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas
Where
Baltimore
Age
18 years and over
People
15
Run by
University of Maryland, Baltimore
See details and how to joinNCT07168486
Phase 1Taking people
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Where
Cleveland
Age
18 years and over
People
15
Run by
Paolo Caimi, MD
See details and how to joinNCT07225439
Phase 2Taking people
A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
Where
Houston
Age
18 years and over
People
20
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT06043323